IP Library Granted Patent US 10,101,340
Granted Patent B2
US 10,101,340 · App. 13/901,819 · Granted Oct 16, 2018

Method of detecting a urine protein fragment and a serum protein fragment

Inventors: Wei-Ya Lin (Dali, TW); Mary Ya-Ping Yeh (Taipei, TW); Tzu-Ling Tseng (Xinzhuang, TW); Ping-Fu Cheng (Xizhou Township, TW); Tsai-Wei Hsu (Zhunan Township, TW); Hung-Yi Li (Xinying, TW); Yi-Ting Chen (Taoyuan County, TW); Yuh-Feng Ling (Taipei, TW); Jin-Shuen Chen (Taipei, TW); Yen-Peng Li (Taipei, TW)
Assignee: Bio Preventive Medicine Corp.
G01N33/6893G01N2333/4728G01N2333/52G01N2333/71G01N2333/8125G01N2800/347G01N2800/52G01N2800/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,101,340
App. No.
13/901,819
Granted
Oct 16, 2018
Kind
B2
Abstract

Described is a method of detecting a protein fragment in a urine sample and a serum sample. The protein fragment is a urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, or serum osteopontin fragment. The urine sample and the serum sample are obtained from the same individual.

Claims (20)

1. A method of detecting a protein fragment, comprising:

(i) detecting in a urine sample the level of a urine protein fragment selected from the group consisting of VVSLGSPSGEVSHPRKT (SEQ ID NO:1), MGVVSLGSPSGEVSHPRKT (SEQ ID NO:2), KGKWERPFEVKDTEEEDF (SEQ ID NO:3), EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAE (SEQ ID NO:5), EDPQGDAAQKTDTSHHDQDHPTFNKITPNLAEFA (SEQ ID NO:6), YPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSK (SEQ ID NO:8) or KYPDAVATWLNPDPSQKQNLLAPQTLPSK (SEQ ID NO:9); and

(ii) detecting in a serum sample the level of a serum protein fragment selected from the group consisting of YPDAVATWLNPDPSQKQNLLAPQNAVSSEETNDFKQETLPSK (SEQ ID NO:8) and KYPDAVATWLNPDPSQKQNLLAPQTLPSK (SEQ ID NO:9), wherein if detecting SEQ ID NO:8 is performed in the serum sample, detecting SEQ ID NO:8 is not performed in the urine sample, and if detecting SEQ ID NO:9 is performed in the serum sample, detecting SEQ ID NO:9 is not performed in the urine sample, the urine sample and the serum sample being obtained from the same subject.

2. The method of claim 1 , wherein the level of a urine protein fragment selected from the group consisting of SEQ ID NOs:3, 5, and 6 is detected in the urine sample.

3. The method of claim 2 , wherein the urine protein fragment detected is SEQ ID NO:3.

4. The method of claim 2 , wherein the urine protein fragment detected is SEQ ID NO:5.

5. The method of claim 2 , wherein the urine protein fragment detected is SEQ ID NO:6.

6. The method of claim 2 , further comprising detecting the level of a different urine protein fragment selected from the group consisting of SEQ ID NO:1, 2, and 7 in the urine sample.

7. The method of claim 6 , wherein the different urine protein fragment is SEQ ID NO:1 or 2.

8. The method of claim 7 , further comprising detecting in the urine sample the level of SEQ ID NO:7.

9. The method of claim 8 , further comprising detecting in the serum sample the level of SEQ ID NO:8.

10. The method of claim 8 , further comprising detecting in the urine sample the level of SEQ ID NO: 8.

11. The method of claim 6 , wherein the different urine protein fragment is SEQ ID NO:7.

12. The method of claim 1 , wherein detecting steps (i) and (ii) are both performed with an immune assay.

13. The method of claim 1 , wherein the level of a urine protein fragment selected from the group consisting of SEQ ID NOs:1, 2, 3, 5, and 6 is detected in the urine sample.

14. The method of claim 13 , further comprising detecting in the urine sample the level of SEQ ID NO:7.

15. The method of claim 1 , wherein the level of a urine protein fragment selected from the group consisting of SEQ ID NOs:1, 2, 3, 5, 6, and 8 is detected in the urine sample and the level of serum protein fragment SEQ ID NO: 9 is detected in the serum sample.

16. The method of claim 15 , further comprising detecting in the urine sample the level of SEQ ID NO:7.

17. The method of claim 1 , wherein the level of a urine protein fragment selected from the group consisting of SEQ ID NOs:1, 2, 3, 5, 6, and 9 is detected in the urine sample and the level of serum protein fragment SEQ ID NO: 8 is detected in the serum sample.

18. The method of claim 17 , further comprising detecting in the urine sample the level of SEQ ID NO:7.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 17, 2018
From: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
To: BIO PREVENTIVE MEDICINE CORP.
Reel/Frame 046367/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2013
From: LIN, WEI-YA; YEH, MARY YA-PING; TSENG, TZU-LING; CHENG, PING-FU; HSU, TSAI-WEI; LI, HUNG-YI; CHEN, YI-TING; LING, YUH-FENG; CHEN, JIN-SHUEN; LI, YEN PENG
To: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
Reel/Frame 030721/0442 →
Continuity (3)
Continuation 12694575 · Jan 27, 2010
Provisional Application 61147778 · Jan 28, 2009
Related Publication 20130252267A1 · Sep 26, 2013